At a glance
- Originator Pfizer
- Class Analgesics; Anti-inflammatories; Antidepressants; Antipsychotics; Anxiolytics; Isoxazoles; Pyridines; Small molecules
- Mechanism of Action Opioid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Epilepsy; Neuromuscular disorders; Pain; Psychotic disorders; Stroke
Most Recent Events
- 30 Sep 1998 No-Development-Reported for Epilepsy in USA (Unknown route)
- 30 Sep 1998 No-Development-Reported for Neuromuscular disorders in USA (Unknown route)
- 30 Sep 1998 No-Development-Reported for Pain in USA (Unknown route)